Humana Inc. (NYSE:HUM) Shares Purchased by Ellsworth Advisors LLC

Ellsworth Advisors LLC grew its stake in shares of Humana Inc. (NYSE:HUM) by 3.8% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 9,451 shares of the insurance provider’s stock after acquiring an additional 347 shares during the quarter. Humana comprises about 1.4% of Ellsworth Advisors LLC’s holdings, making the stock its 29th largest position. Ellsworth Advisors LLC’s holdings in Humana were worth $4,327,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors and hedge funds also recently modified their holdings of the company. Sunbelt Securities Inc. acquired a new position in shares of Humana during the 1st quarter valued at about $28,000. Baystate Wealth Management LLC grew its holdings in shares of Humana by 84.1% during the 2nd quarter. Baystate Wealth Management LLC now owns 81 shares of the insurance provider’s stock worth $37,000 after purchasing an additional 37 shares during the period. Householder Group Estate & Retirement Specialist LLC purchased a new stake in shares of Humana during the 3rd quarter worth about $39,000. Nvwm LLC grew its holdings in shares of Humana by 41.0% during the 3rd quarter. Nvwm LLC now owns 86 shares of the insurance provider’s stock worth $42,000 after purchasing an additional 25 shares during the period. Finally, Operose Advisors LLC purchased a new position in Humana in the 3rd quarter worth approximately $56,000. Institutional investors and hedge funds own 92.38% of the company’s stock.

Insider Buying and Selling at Humana

In other Humana news, Director Jorge S. Mesquita bought 545 shares of the stock in a transaction on Tuesday, February 20th. The shares were purchased at an average price of $367.09 per share, with a total value of $200,064.05. Following the acquisition, the director now directly owns 2,578 shares of the company’s stock, valued at approximately $946,358.02. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Insiders own 0.32% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities analysts have weighed in on HUM shares. Truist Financial restated a “hold” rating and issued a $550.00 price target on shares of Humana in a report on Friday, January 19th. Wells Fargo & Company decreased their price target on Humana from $465.00 to $413.00 and set an “overweight” rating for the company in a report on Tuesday, January 30th. Mizuho decreased their price target on Humana from $550.00 to $400.00 and set a “buy” rating for the company in a report on Friday, January 26th. Barclays started coverage on Humana in a report on Wednesday, March 6th. They issued an “equal weight” rating and a $356.00 price target for the company. Finally, Raymond James began coverage on Humana in a report on Friday, March 22nd. They issued a “market perform” rating for the company. Ten analysts have rated the stock with a hold rating and nine have given a buy rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of “Hold” and a consensus price target of $494.00.

Humana Stock Performance

Shares of HUM traded down $2.78 during trading hours on Friday, reaching $346.72. 1,583,052 shares of the company’s stock traded hands, compared to its average volume of 1,477,071. The business’s fifty day simple moving average is $362.42 and its two-hundred day simple moving average is $442.64. Humana Inc. has a twelve month low of $334.54 and a twelve month high of $541.21. The firm has a market capitalization of $41.83 billion, a price-to-earnings ratio of 17.49, a P/E/G ratio of 2.05 and a beta of 0.45. The company has a debt-to-equity ratio of 0.63, a current ratio of 1.59 and a quick ratio of 1.59.

Humana (NYSE:HUM) last posted its quarterly earnings results on Thursday, January 25th. The insurance provider reported ($0.11) earnings per share for the quarter, missing analysts’ consensus estimates of $0.76 by ($0.87). Humana had a return on equity of 19.44% and a net margin of 2.34%. The firm had revenue of $26.46 billion for the quarter, compared to analysts’ expectations of $25.47 billion. During the same period last year, the business earned $1.62 earnings per share. The firm’s revenue for the quarter was up 17.9% on a year-over-year basis. Analysts predict that Humana Inc. will post 16.04 earnings per share for the current year.

Humana Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, April 26th. Shareholders of record on Friday, March 29th will be issued a $0.885 dividend. This represents a $3.54 dividend on an annualized basis and a yield of 1.02%. The ex-dividend date is Wednesday, March 27th. Humana’s dividend payout ratio (DPR) is currently 17.86%.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.